Drugline is a fortnightly electronic drug bulletin for health professionals.


Drugline is a fortnightly electronic drug bulletin providing information on new medicines, new developments, current affairs, new indications, new PBS listings and deletions and general issues of importance to all health professionals. Click below to view the most recent volumes of Drugline.

New Warning for Febuxostat

Drugline Volume 379

The Therapeutic Goods Administration (TGA) has added a boxed warning to febuxostat tablets advising of an increased risk of death in patients with established cardiovascular disease. The addition of this warning follows the publication…

Read more

Naloxone Nasal Spray

Drugline Volume 378

A naloxone nasal spray is now available for the emergency treatment of known or suspected opioid overdose. Nyxoid® is a single-dose nasal spray containing 1.8mg of naloxone in a 0.1mL solution. Naloxone is an…

Read more

Anticoagulants in Antiphospholipid Syndrome

Drugline Volume 377

The Therapeutic Goods Administration (TGA) is updating product information documents for direct acting oral anticoagulants (DOACs) to advise of the increased risk of recurrent thrombotic events in patients with antiphospholipid syndrome. Antiphospholipid syndrome is…

Read more

Local Anaesthetics for Oromucosal Use

Drugline Volume 376

Painful conditions of the mouth are uncomfortable and can significantly impair oral intake of fluid and nutrition. Mucositis is often cited as the most debilitating side effect of cancer chemotherapy and radiotherapy. Options recommended…

Read more

Rufinamide for Lennox-Gastaut Syndrome

Drugline Volume 375

Rufinamide is a new adjunctive therapy in the treatment of seizures associated with Lennox-Gastaut syndrome (LGS). LGS is a severe form of epilepsy that presents with multiple types of seizures and is often refractory…

Read more

New Treatment for Carcinoid Syndrome

Clinical Article

Telotristat is a new medication for the treatment of carcinoid syndrome diarrhoea. Carcinoid syndrome is a condition that develops in around 10% of people with a carcinoid tumour. Carcinoid tumours develop from enterochromaffin cells,…

Read more
Load More

October 2019

New Warning for Febuxostat (Oct. 18 2019)

Naloxone Nasal Spray (Oct. 04 2019)

April 2019

New High-Strength Insulin (Apr. 18 2019)

Tofacitinib Safety Issue (Apr. 05 2019)

March 2019

February 2019

January 2019

December 2018

October 2018

September 2018

August 2018

July 2018

April 2018

January 2018

December 2017

September 2017

Thunderstorm Asthma (Sep. 21 2017)

The Efficacy of Perampanel (Sep. 08 2017)

July 2017

June 2017

April 2017

March 2017

November 2016

September 2016

August 2016

April 2016

November 2015

Viekira Pak for Hepatitis C (Nov. 19 2015)

Micafungin (Nov. 05 2015)

October 2015

Dabigatran Antidote on the Horizon (Oct. 22 2015)

Akynzeo® (Oct. 08 2015)

September 2015

May 2015

April 2015

Victoza (liraglutide) (Apr. 23 2015)

Ultibro Breezhaler 100/50 (Apr. 09 2015)

March 2015

February 2015

December 2014

November 2014

October 2014

September 2014

World Pharmacist Day (Sep. 24 2014)

National Stroke Week (Sep. 11 2014)

August 2014

July 2014

Breo™ Ellipta® (Jul. 31 2014)

Use of Prolia® in Men (Jul. 17 2014)

Adcetris® (brentuximab vedotin) (Jul. 03 2014)

April 2014

March 2014

September 2013

August 2013

July 2013

June 2013

Riluzole for Motor Neurone Disease (Jun. 20 2013)

Mycamine (Jun. 06 2013)

May 2013

HPV Vaccine (May. 23 2013)

World Lupus Day (May. 09 2013)

December 2012

November 2012

August 2012